Life Spine has announced the first clinical uses of its TiBow minimally invasive transforaminal lumbar interbody fusion (TLIF) expandable spacer system featuring Osseo-Loc surface technology with James Lynch of Reno, USA, and John Anson of Las Vegas, USA.
TiBow joins Life Spine’s portfolio of micro invasive and expandable products cleared by the US Food and Drug Administration (FDA). The system is designed to allow for in-situ expansion for increased endplate coverage and stability, for minimally invasive TLIF and oblique approaches. With a number of lordotic options, TiBow is intended to provide the surgeon the ability to restore normal sagittal alignment while building upon Life Spine’s commitment of offering ground-breaking procedural solutions.
TiBow features the company’s Osseo-Loc surface technology, which creates a geometric surface architecture designed to provide an osteophylic environment, documented for the recruitment of bone building cells (osteoblasts) on titanium implants.
“Life Spine has set out to build an expandable product platform that reflects many of the unmet needs of its surgeon customers, as well as challenges associated with micro invasive TLIF procedures,” Anson notes. “The design of this system addresses common challenges associated with narrow TLIF devices by providing an expandable footprint and unimpeded graft aperture. I believe TiBow is a safe and effective option for my patients, while potentially offering less pain and the ability to return to work faster.”
